Open original FDA record ↗Recall record
- FDA identifier
- Z-1537-2014
- Company in FDA record
- Bio-Rad Laboratories, Inc.
- FDA classification date
- May 2, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
There is an issue with the buffers which impacts the quantification of the Hemoglobin F peak. Calibration and Quality control are likely to fail if the affected lots are used.
Source facts
- Action
- BIO-RAD Laboratories sent an URGENT: MEDICAL DEVICE LETTER in the US on April 8. 2014 and worldwide with letters sent to customers and subsidiaries on April 14, 2014. Subsidiaries were asked to translate the letter and distribute to all affected customers Custormer were asked to complete a CUSTOMER MEDICAL DEVICE CORRECTION RESPONSE FORM and fax it to the Bio-Rad CSD Regulatory Affairs Department at the number provided to confirm that you have received this important information
- Initiated
- 2014-04-08
- Root cause
- Nonconforming Material/Component
- Terminated
- 2014-05-30
- Distribution
- Worldwide Distrubution ; USA INCLUDING CA, NY, GA, NC, AL, NJ, CT, WA, NY, LA, Il, MA and Internationally to China, Australia, Canada, France, Great Britain, Hong Kong, Thailand, Singapore,and Brazil.
- Recall number
- Z-1537-2014
- Recall status
- Terminated
- CDRH record ID
- 126790
- FDA classified
- 2014-05-02
- Recall event number
- 68016